OTCMKTS:TRXD

Trxade Group Stock Forecast, Price & News

$5.87

-0.11 (-1.84 %)

(As of 01/15/2021 12:00 AM ET)

Add

Compare

Today's Range

$5.70

Now: $5.87▼

$6.09

50-Day Range

$1.50

MA: $5.01▼

$5.98

52-Week Range

$0.35

Now: $5.87▼

$1.76

Volume116,644 shs

Average Volume4,247 shs

Market Capitalization$230.32 million

P/E RatioN/A

Dividend YieldN/A

Beta1.35

Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the United States pharmaceutical industry. The company offers Web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com and InventoryRx.com, which are Web-based pharmaceutical marketplaces; Pharmabayonline that provides access to proprietary pharmaceutical data analytics to the United States-based independent pharmacies, pharmaceutical shortage databases, proposed governmental reimbursement benchmarks comparison and analysis, and a proprietary suggested national retail drug benchmark; and RxGuru, a service-based desktop software application, which provides daily drug pricing and analytics to the independent pharmacists. The company distributes its services through its online platform to independent pharmacies and pharmaceutical suppliers in 18 states of the United States. Trxade Group, Inc. is based in Land O' Lakes, Florida.

MarketRank^™

Overall MarketRank^™

0.79 out of 5 stars

Retail/Wholesale Sector

249th out of 333 stocks

Drugs, Proprietaries, & Sundries Industry

8th out of 10 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Trxade Group.

2.3 Community Rank

Outperform Votes
Trxade Group has received 133 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Trxade Group has received 156 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Trxade Group has received 53.98% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Trxade Group and other stocks. Vote “Outperform” if you believe TRXD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TRXD will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Trxade Group does not currently pay a dividend.
Dividend Growth
Trxade Group does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Trxade Group insiders have not sold or bought any company stock.
Percentage Held by Insiders
71.30% of the stock of Trxade Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Trxade Group is -587.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Trxade Group is -587.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Trxade Group has a P/B Ratio of 195.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Drugs, proprietaries, & sundries

Sub-IndustryN/A

SectorRetail/Wholesale

Current SymbolOTCMKTS:TRXD

Previous Symbol

CUSIPN/A

CIK1382574

Webwww.trxade.com

Phone800-261-0281

Employees31

Debt

Debt-to-Equity Ratio0.26

Current Ratio4.51

Quick Ratio4.45

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$3.83 million

Price / Sales60.13

Cash Flow$0.00 per share

Price / Cash Flow5,362.12

Book Value$0.03 per share

Price / Book195.67

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$10,000.00

Net Margins0.33%

Return on Equity1.26%

Return on Assets0.61%

Miscellaneous

Outstanding Shares39,236,000

Market Cap$230.32 million

Next Earnings DateN/A

OptionableNot Optionable

$5.87

-0.11 (-1.84 %)

(As of 01/15/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive TRXD News and Ratings via Email

Sign-up to receive the latest news and ratings for TRXD and its competitors with MarketBeat's FREE daily newsletter.

Trxade Group (OTCMKTS:TRXD) Frequently Asked Questions

How has Trxade Group's stock price been impacted by Coronavirus (COVID-19)?

Trxade Group's stock was trading at $4.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TRXD stock has increased by 18.3% and is now trading at $5.87.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Trxade Group?

Wall Street analysts have given Trxade Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Trxade Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Trxade Group's key competitors?

Some companies that are related to Trxade Group include Trxade Group (MEDS), Bioasis Technologies (BIOAF), ScripsAmerica (SCRCQ), China Medicine (CHME), China BCT Pharmacy Group (CNBI) and Medizone International (MZEIQ).
View all of TRXD's competitors.

What other stocks do shareholders of Trxade Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trxade Group investors own include Herbalife Nutrition (HLF), Abercrombie & Fitch (ANF), Arsanis (ASNS), Bertrandt Aktiengesellschaft (BDT.F) (BDT), Cummins (CMI), Citius Pharmaceuticals (CTXR), J Sainsbury (JSAIY), Lonestar Resources US (LONE), Nektar Therapeutics (NKTR) and Pattern Energy Group (PEGI).

Who are Trxade Group's key executives?

Trxade Group's management team includes the following people:

Mr. Surendra K. Ajjarapu, Founder, Chairman, CEO & Sec. (Age 48)
Mr. Prashant Patel, Founder, Pres, COO & Director (Age 45)
Mr. Howard A. Doss, Chief Financial Officer (Age 65)
Dr. Ramesh Kenchappa M.S.(Pharma), Ph.D., Chief Scientific Officer
Mr. Steven D. Lee Esq., Gen. Counsel

What is Trxade Group's stock symbol?

Trxade Group trades on the OTCMKTS under the ticker symbol "TRXD."

How do I buy shares of Trxade Group?

Shares of TRXD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Trxade Group's stock price today?

One share of TRXD stock can currently be purchased for approximately $5.87.

How big of a company is Trxade Group?

Trxade Group has a market capitalization of $230.32 million and generates $3.83 million in revenue each year. Trxade Group employs 31 workers across the globe.

What is Trxade Group's official website?

The official website for Trxade Group is www.trxade.com.

How can I contact Trxade Group?

Trxade Group's mailing address is 3840 Land O' Lakes Blvd., Land O' Lakes FL, 34639. The company can be reached via phone at 800-261-0281 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here